These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Pharmacological and clinical profile of linaclotide (Linzess Keto Y; Kosako M Nihon Yakurigaku Zasshi; 2019; 153(6):289-298. PubMed ID: 31178535 [TBL] [Abstract][Full Text] [Related]
3. Optimizing the Use of Linaclotide in Patients with Constipation-Predominant Irritable Bowel Syndrome: An Expert Consensus Report. Rey E; Mearin F; Alcedo J; Ciriza C; Delgado-Aros S; Freitas T; Mascarenhas M; MÃnguez M; Santos J; Serra J Adv Ther; 2017 Mar; 34(3):587-598. PubMed ID: 28083815 [TBL] [Abstract][Full Text] [Related]
4. Effect of linaclotide on severe abdominal symptoms in patients with irritable bowel syndrome with constipation. Rao SS; Quigley EM; Shiff SJ; Lavins BJ; Kurtz CB; MacDougall JE; Currie MG; Johnston JM Clin Gastroenterol Hepatol; 2014 Apr; 12(4):616-23. PubMed ID: 24075889 [TBL] [Abstract][Full Text] [Related]
5. Review article: Linaclotide for the management of irritable bowel syndrome with constipation. Layer P; Stanghellini V Aliment Pharmacol Ther; 2014 Feb; 39(4):371-84. PubMed ID: 24433216 [TBL] [Abstract][Full Text] [Related]
6. Linaclotide: a novel agent for chronic constipation and irritable bowel syndrome. Love BL; Johnson A; Smith LS Am J Health Syst Pharm; 2014 Jul; 71(13):1081-91. PubMed ID: 24939497 [TBL] [Abstract][Full Text] [Related]
7. Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions. Yang Y; Fang J; Guo X; Dai N; Shen X; Yang Y; Sun J; Bhandari BR; Reasner DS; Cronin JA; Currie MG; Johnston JM; Zeng P; Montreewasuwat N; Chen GZ; Lim S J Gastroenterol Hepatol; 2018 May; 33(5):980-989. PubMed ID: 29319191 [TBL] [Abstract][Full Text] [Related]
8. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis. Videlock EJ; Cheng V; Cremonini F Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System. Chang L; Lacy BE; Moshiree B; Kassebaum A; Abel JL; Hanlon J; Bartolini W; Boinpally R; Bochenek W; Fox SM; Mallick M; Tripp K; Omniewski N; Shea E; Borgstein N Am J Gastroenterol; 2021 Sep; 116(9):1929-1937. PubMed ID: 34465695 [TBL] [Abstract][Full Text] [Related]
10. A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation. Johnston JM; Shiff SJ; Quigley EM Curr Med Res Opin; 2013 Feb; 29(2):149-60. PubMed ID: 23198977 [TBL] [Abstract][Full Text] [Related]
11. Linaclotide: a novel compound for the treatment of irritable bowel syndrome with constipation. Rothstein RD; Friedenberg FK Expert Opin Pharmacother; 2013 Oct; 14(15):2125-32. PubMed ID: 24007408 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide. Chandar AK Int J Gen Med; 2017; 10():385-393. PubMed ID: 29184433 [TBL] [Abstract][Full Text] [Related]
13. Linaclotide, novel therapy for the treatment of chronic idiopathic constipation and constipation-predominant irritable bowel syndrome. Vazquez-Roque MI; Bouras EP Adv Ther; 2013 Mar; 30(3):203-11. PubMed ID: 23436110 [TBL] [Abstract][Full Text] [Related]
14. Linaclotide: new mechanisms and new promise for treatment in constipation and irritable bowel syndrome. Sood R; Ford AC Ther Adv Chronic Dis; 2013 Nov; 4(6):268-76. PubMed ID: 24179669 [TBL] [Abstract][Full Text] [Related]
15. Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents. Thomas RH; Luthin DR Pharmacotherapy; 2015 Jun; 35(6):613-30. PubMed ID: 26016701 [TBL] [Abstract][Full Text] [Related]
16. Linaclotide for constipation-predominant IBS. Drug Ther Bull; 2013 Nov; 51(11):129-32. PubMed ID: 24227771 [TBL] [Abstract][Full Text] [Related]
17. Linaclotide: a new option for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation in adults. Parker CH; Yuan Y; Liu LW Clin Med Insights Gastroenterol; 2013; 6():21-32. PubMed ID: 24833940 [TBL] [Abstract][Full Text] [Related]
18. Linaclotide in the management of gastrointestinal tract disorders. Lacy BE; Levenick JM; Crowell MD Drugs Today (Barc); 2012 Mar; 48(3):197-206. PubMed ID: 22462039 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis. Shah ED; Kim HM; Schoenfeld P Am J Gastroenterol; 2018 Mar; 113(3):329-338. PubMed ID: 29380823 [TBL] [Abstract][Full Text] [Related]
20. Linaclotide: evidence for its potential use in irritable bowel syndrome and chronic constipation. Lee N; Wald A Core Evid; 2012; 7():39-47. PubMed ID: 22807692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]